A detailed history of Scott Marsh Financial, LLC transactions in Vericel Corp stock. As of the latest transaction made, Scott Marsh Financial, LLC holds 14,671 shares of VCEL stock, worth $491,331. This represents 0.23% of its overall portfolio holdings.

Number of Shares
14,671
Holding current value
$491,331
% of portfolio
0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$37.92 - $45.7 $556,324 - $670,464
14,671 New
14,671 $624 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.58B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Scott Marsh Financial, LLC Portfolio

Follow Scott Marsh Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott Marsh Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scott Marsh Financial, LLC with notifications on news.